New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
16:17 EDTBLUEbluebird bio reports Q2 EPS (6c), consensus (45c)
Reports Q2 revenue $6.34M, consensus $6.15M. Anticipated 2014 milestones: Present further clinical results in beta-thalassemia major from HGB-205 and Northstar Studies in late 2014 and transplant first sickle cell disease patient with LentiGlobin product candidate.
News For BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
07:06 EDTBLUEFierce Biotech to hold a breakfast meeting
Subscribe for More Information
October 14, 2014
07:04 EDTBLUEbluebird bio says first patient with sicle cell disease undergoes infusion
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use